ProShare Advisors’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-8,392
| Closed | -$1.1M | – | 2265 |
|
|
2020
Q4 | $1.1M | Buy |
8,392
+836
| +11% | +$110K | ﹤0.01% | 837 |
|
|
2020
Q3 | $382K | Sell |
7,556
-90
| -1% | -$4.55K | ﹤0.01% | 1051 |
|
|
2020
Q2 | $364K | Buy |
7,646
+1,822
| +31% | +$86.7K | ﹤0.01% | 1113 |
|
|
2020
Q1 | $285K | Sell |
5,824
-3,813
| -40% | -$187K | ﹤0.01% | 895 |
|
|
2019
Q4 | $553K | Sell |
9,637
-1,607
| -14% | -$92.2K | ﹤0.01% | 1018 |
|
|
2019
Q3 | $404K | Sell |
11,244
-1,222
| -10% | -$43.9K | ﹤0.01% | 1066 |
|
|
2019
Q2 | $387K | Sell |
12,466
-1,782
| -13% | -$55.3K | ﹤0.01% | 1127 |
|
|
2019
Q1 | $334K | Buy |
14,248
+1,030
| +8% | +$24.1K | ﹤0.01% | 1197 |
|
|
2018
Q4 | $182K | Buy |
+13,218
| New | +$182K | ﹤0.01% | 1393 |
|